Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## Laboratory Animal Science Association 


Unaudited Financial Statements For the year ended 30 June 2025 

**Company Number: 08707797 (England & Wales) Charity Number: 1164804** 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

## CONTENTS 


**----- Start of picture text -----**<br>
Page<br>Reference and Administrative Details 1<br>Report of the Board of Trustees 2 to 6<br>Independent Examiner's report 7<br>Statement of Financial Activities 8<br>Balance Sheet 9<br>Notes to the Financial Statements 10 to 14<br>**----- End of picture text -----**<br>




Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

Reference and Administrative Details For the year ended 30 June 2025 

**Company Number:** 08707797 **Charity Number:** 1164804 **Registered Office:** 6th Floor 9 Appold Street London, England EC2A 2AP **Directors and Trustees:** Dr Jordi Lopez Tremoleda Dr Sally Robinson Dr Sara Elizabeth Wells (appointed 1 January 2025) Dr Susan Clare Stanford (resigned 1 January 2025) Dr Jill Reckless (resigned 1 January 2025) **Independent examiner** Moore Kingston Smith LLP 6th Floor 9 Appold Street London EC2A 2AP 

1 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025 

_________________________________________________________________________ 

The trustees of Laboratory Animal Science Association (“LASA”), who are also directors of the charitable company for the purposes of the Companies Act 2006, present their report together with the financial statements for the year ended 30 June 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommend Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102). 

## **Structure, Governance and Management** 

LASA is a charitable company governed by its Memorandum and Articles of Association. 

LASA is run by an Executive Committee comprising the three trustees of the charity plus the treasurer, supported by a team of elected members, who collectively comprise LASA Council. 

New trustees must be nominated (and seconded) by any two members of LASA, with subsequent election at the Annual General Meeting. Currently, there are three trustees, one of whom (Chair of the Scientific Committee) will be standing down at the end of the year. One new trustee will be elected at the AGM in November 2025 to fulfil this role. 

LASA occasionally collaborates with other organisations for example: the Institute of Animal Technicians, Royal Society for the Protection of Animals, Laboratory Animal Veterinary Association, National Centre for the Replacement, Refinement and Reduction of Animal Research (NC3Rs), UK Biosciences Sector Coalition, Federation of Laboratory Animals Science Associations and Understanding Animal Research. However, these activities are project-driven and have no financial implications or obligations. 

Some members of LASA Council are also members of other organisations, which helps to promote these collaborations and common interests. Arising from those relationships, all members of Council are required to provide a signed Declaration of Interests on their election as trustee or member of Council. LASA requires both trustees and council members to update this information annually. 

## **Objective and Activities** 

The objects of the charitable company are to promote the advancement of laboratory animal science for the benefit of the public. 

In furtherance of this object, but not otherwise: 

- to promote the interchange of scientific information among persons interested in laboratory animal science by means of meetings, webinars, lectures, demonstrations, discussions and publications, as appropriate. 

- to encourage and provide education and training in laboratory animal science. 

The charitable company’s main activities in relations to those objects are: 

- the delivery of continued education and promotion / dissemination of developments in the 3Rs (Replacement, Reduction, Refinement), laboratory animal welfare and good research practice to all professionals engaged in laboratory animal science. 

This is achieved through: 

- scientific meetings 

- training workshops 

- the drafting and production of publications and guidance on good practice in laboratory animal science 

- engagement with the Concordat on Openness. 

- engagement with Government to improve the regulation of animal scientific research and its implementation and transparency: for instance, through comment and feedback on proposals for development of new processes and procedures for regulation of animal science by the Animals in Science Regulation Unit 

2 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025 

_________________________________________________________________________ 

- award of bursaries to members to promote development and dissemination of good practice in laboratory animal science. Bursaries are available for LASA members to help cover the cost of their attendance at / contributions to any event considered relevant to LASA’s mission and objectives. Members can apply for a LASA bursary at any time of the year. Individuals who have no alternative sources of funding to support such activities are especially encouraged to apply. The criteria that must be satisfied for an application to be considered for the award of a bursary, together with the terms and conditions of the award. The recipient is made aware of these when a bursary is awarded. Note: bursaries are claimed retrospectively, subject to confirmation of expenses and receipt of a report on the scientific benefits accruing from the award, or equivalent output. 

The trustees have regard to the Charity Commission’s guidance on public benefit when reviewing their aims and objectives and in planning future activities. 

All LASA’s Officers hold honorary posts and all LASA’s activities depend entirely on the voluntary efforts of its members. Such activities include, but are not limited to: 

- the planning and delivery of scientific meetings, including events providing training and continuing education as well as recent developments in the 3Rs, laboratory animal welfare and good research practice and laboratory animal science 

- the drafting and publication of documents providing guidance on good practice in laboratory animal science (free download from LASA website) 

- offering expert feedback on matters concerning the regulation of laboratory animal science in the UK and beyond 

## **Achievements and Performance** 

**The LASA Annual Meeting 2024** was successfully delivered and achieved its objectives of promoting best practices in laboratory animal science and welfare. The event was organized with the support of LASA members, Council, Executive Committee, Section Convenors, trade partners, and the RSB Events Team. Feedback from attendees confirmed the value of the scientific content, networking opportunities, and overall organization. 

The meeting adopted a new format consisting of two half-day sessions and one full day, which improved accessibility and logistics for participants. Returning to a previous venue ensured highquality hosting and catering services, which were widely praised by attendees (over 200 attendees). 

The scientific program was multidisciplinary and included sessions on species-specific welfare for fish, rodents and farm animals, as well as discussions on affective states, aging, staff training, and strategies for fostering interdisciplinary collaboration. Keynote presentations were delivered by Professor Stuart Peirson from the University of Oxford, Dr. Fiona Sewell from NC3Rs, and Professor Karen Blyth from the CRUK Scotland Institute. Additional contributions came from leading experts in animal welfare and research, further enriching the program. 

Training and special sessions were also a key feature of the meeting. Establishment Licence Holder (PELH) training sessions were well attended and supported by ASPU and ASRU. Other sessions focused on animal sentience and innovation in animal science and the 3Rs, with the latter supported by NC3Rs. 

Recognition was given to outstanding contributions during the event. Dr. Stuart Ainsworth received the award for best talk for his presentation on a substantially refined pre-clinical murine model for coagulopathic snakebite envenoming, an award supported by the Animals in Science Education Trust. Dr Cat Beatty won the best poster award, sponsored by Envigo/Inotiv, for her work on developing a monitoring and treatment regimen for NSG mice displaying phenotypic tarsal joint swelling and hock lesions. 

Trade partners played an integral role in the success of the meeting, providing excellent exhibits and creating vibrant networking opportunities that added significant value to the event. LASA extends its sincere thanks to all contributors for their commitment to advancing animal welfare, science, and the principles of the 3Rs. 

3 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025 

_________________________________________________________________________ 

Our next Annual meeting, a core feature of our activities **,** will be held in November 2025. The LASA Annual Meeting 2025 will focus on the theme Modelling Biology and Its Impact on Science and Welfare. The event is designed to showcase a diverse range of species, technologies, and advanced animal models, emphasizing the role of animal research in driving scientific progress while maintaining the highest standards of animal welfare. 

The PELh Section held their annual Establishment Licence Holders’ Forum in October 2024. This focused on the theme ‘Supporting Your Named Persons’. The meeting was instrumental to continue to support the regulated establishments across the UK. Speakers included members of the LAS community, members of the Home Office Animal Science Regulatory and Policy units, with over 80 attendees 

## **Other key activities include:** 

A major development for LASA was the change in arrangements for the Secretariat:  for many years, this had been outsourced to Agenda Resource Management but, since 1st January 2024, is now provided by the staff at the Royal Society for Biology.  This change has offered an opportunity for LASA and the Secretariat to review and refine some operating procedures and activities. 

## **A Review of LASA SECTIONs.** 

In 2024 we made several changes to the sections (highlighted in last year’s report).  In 2025 we have considered how the sections can be more effective and have appointed a new council role to coordinate the sections and their work.  As a reminder our sections are 

- _Care, Welfare, Husbandry and Facility Management_ 

- _Education, Training and Ethics Section_ (ETES) 

- _Genetically Altered Animals_ 

- _Innovations in Animal Science and the 3Rs_ 

- _Large Animal Research Network_ (LARN). 

- _HOLTIF_ 

- _PEL forum_ 

**DOPS** _._ LASA hosts over 250 DOPS (Direct Observation of Procedural Skills) supplied by several organisations. We have decided to review our approach to DOPS and have currently removed access to these from the LASA Website. This decision is based on LASA’s resources, costs and governance processes. 

## **Financial Review** 

LASA’s end-of-year balance stands at £258,052, continuing the improvement reported last year despite a sizeable decrease in total income to £158,743 (2024: £210,512). 

A larger proportion of income this year was derived from members’ subscriptions (£29,271, up from £16,509), placing the charity in the desirable position that a greater share of administrative costs is now covered by membership fees. 

The improved year-end balance, in the face of reduced total income, reflects the reduction in overall expenditure from £150,223 to £128,378. The primary contributor to this saving was lower meetingrelated expenditure, which fell from £95,935 to £77,915. 

Administrative costs rose modestly (£28,243, up from £25,772), reflecting ongoing work to bring bookkeeping in-house and the higher service charges from the Royal Society of Biology (RSB). While these costs remain above historical levels, the move has the potential to improve transparency and efficiency in our financial management. 

For 2025/26, we will continue to work closely with RSB to review the value provided, identify potential savings, and ensure that LASA’s administrative expenditure remains proportionate to the organisation’s income and activity levels. 

4 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025 

_________________________________________________________________________ 

The overall net surplus for the year was £30,365, enabling LASA to further strengthen its reserves and maintain a sound financial position going forward. 

LASA reviewed and awarded six bursaries in this financial year.  Four of these supported attendance at the FELASA Congress in June 2025 and so will not have been expensed back in this financial year. The remaining two were for members to attend scientific meetings (Society for Neuroscience conference 2024 and a prosocial workshop at University International of Andalucia respectively). 

## **Reserves Policy** 

At the close of the financial year, LASA’s provisional unrestricted reserves stood at £85,766, representing approximately two-thirds of annual expenditure. This reflects a modest increase from the previous year (£84,999) and continues the positive trend of gradual reserve strengthening. 

The trustees maintain a policy of holding sufficient unrestricted reserves to: 

- ensure LASA can continue its core charitable activities in the event of unforeseen reductions in income or increases in expenditure; 

- provide adequate working capital between major income-generating activities, such as the Annual Conference; and 

- enable the charity to respond flexibly to new opportunities that advance its objectives. 

The trustees’ medium-term objective is to maintain unrestricted reserves equivalent to at least one year’s operating expenditure, with an aspirational long-term target of two years’ expenditure as a prudent safeguard against fluctuations in meeting income, sponsorship, and membership subscriptions. 

The current reserves level is considered adequate but below the desired target. The trustees will continue to monitor the reserves position closely as part of LASA’s financial planning and risk management processes, with the aim of achieving the target level within the next three years through careful expenditure control and sustainable income generation. 

## **Risk Management** 

The trustees recognise that effective risk management is essential to the charity’s governance and long-term sustainability. LASA maintains a Risk Register that is reviewed regularly by Council, with updates discussed whenever significant operational or financial changes occur. The register is used to identify, evaluate, and monitor potential threats to the charity’s activities, reputation, and financial stability, and to ensure appropriate mitigation strategies are in place. 

During 2024/25, particular attention was given to risks arising from the transition of financial management to the Royal Society of Biology and from changes within the Executive team. The Honorary Treasurer role was transferred to a new appointee at the start of the financial year, with the previous Treasurer retained in a new VP position as Academic Liaison Lead to support continuity and maintain close engagement with the academic sector. The former President-Elect has also been retained as VP Biotech Liaison, helping to strengthen LASA’s external partnerships and diversification of funding sources.  These positions are appointments of the LASA President as per the bylaws. 

The trustees consider the principal risks currently facing LASA to be: 

- Reduced attendance at meetings and conferences resulting from tightening travel and expenditure policies across academic institutions and research organisations. 

- General decline in funding available for laboratory animal science, as resources are redirected towards alternative research models and non-animal methodologies. 

- Dependence on annual events as the main source of unrestricted income, leaving the organisation exposed to fluctuations in delegate and sponsor participation. 

- Volunteer capacity and succession planning, given LASA’s reliance on the voluntary contribution of its officers and Council members. 

5 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

LABORATORY ANIMAL SCIENCE ASSOCIATION Trustees’ Annual Report For the year ended 30 June 2025 

_________________________________________________________________________ 

Mitigation measures include: 

- diversifying income streams through strengthened membership engagement, digital events, and partnerships 

- maintaining adequate reserves to cushion against income volatility 

- regular review of financial performance and forward commitments by the Treasurer and Council 

- proactive succession planning for key officer roles to ensure continuity of expertise. 

The trustees remain confident that the controls and monitoring processes in place are proportionate and effective, and that LASA is well positioned to continue delivering its charitable objectives within a managed risk framework. 

## **Statement of responsibilities of the Trustees** 

The Trustees (who are also directors of the charity for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). 

Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charity and of the income and expenditure of the charity for that period. In preparing those financial statements the Trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the Charities SORP; 

- make judgements and accounting estimates that are reasonable and prudent; 

- state whether applicable UK accounting standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements; and 

- prepare the financial statements on a going concern basis unless it is inappropriate to presume that the charity will continue in operation. 

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and which enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. 

This report was approved by the trustees on ….............................. and was signed on its behalf by: 17 December 2025 


Dr S Robinson – Trustee and Honorary Secretary 

6 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

Independent Examiner's Report For the year ended 30 June 2025 

I report to the charity trustees on my examination of the accounts of the Company for the year ended 30 June 2025. 

## **Responsibilities and basis of report** 

As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’). 

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. 

## **Independent Examiner's Statement** 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 

- 1) accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or 2) the accounts do not accord with those records; or 

- 3) the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view which is not a matter considered as part of an independent examination; or 

- 4) the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

## **Adam Fullerton (FCA, DChA)** 

**For and on behalf of Moore Kingston Smith LLP** Chartered Accountants 

6th Floor, 9 Appold Street London EC2A 2AP 

Date: 17 December 2025 

7 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

Statement of Financial Activities For the year ended 30 June 2025 


**----- Start of picture text -----**<br>
Unrestricted funds<br>Notes 2025 2024<br>£ £<br>Income from:<br>Donations & legacies 63,368  37,225<br>Charitable activities 2  94,597  172,740<br>Investments 3  778  547<br>Total  158,743 210,512<br>Expenditure on:<br>Charitable activities 4 128,378  150,223<br>Total  128,378 150,223<br>Net income 30,365 60,289<br>NET MOVEMENT IN FUNDS 30,365 60,289<br>Reconciliation of funds:<br>Fund balance brought forward at 1 July  227,687  167,398<br>2024<br>Fund balance carried forward at 30<br>June 2025 11 258,052  227,687<br>**----- End of picture text -----**<br>


The Statement of Financial Activities includes all gains and losses in the year and therefore a statement of recognised gains and losses has not been prepared. 

All of the above amounts relate to continuing activities. 

The notes on pages 10 to 14 form part of these financial statements. 

8 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

## Balance Sheet 

as at 30 June 2025 


**----- Start of picture text -----**<br>
Notes 2025 2024<br>£ £ £ £<br>CURRENT ASSETS<br>Debtors 9 6,561 64,968<br>Cash at bank and in hand 318,793 259,186<br>325,354 324,154<br>LIABILITIES<br>Creditors: Amounts falling due<br>within one year 10 (67,302) (96,467)<br>NET CURRENT ASSETS 258,052 227,687<br>TOTAL ASSETS LESS CURRENT LIABILITIES 258,052 227,687<br>FUNDS<br>Unrestricted funds 11 258,052 227,687<br>TOTAL FUNDS 258,052 227,687<br>**----- End of picture text -----**<br>


The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025. 

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006. 

The directors acknowledge their responsibility for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements. 

These financial statements have been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006. 

These financial statements were approved by the members of the Trustee Board on 17 December 2025 and signed on their behalf by: 


...................................................... **Dr Sara Elizabeth Wells President - Trustee** 

## **Charity No. 1164804 Company No. 08707797 (England & Wales)** 

The notes on pages 10 to 14 form part of these financial statements. 

9 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

Notes to the accounts 

For the year ended 30 June 2025 

## **1 ACCOUNTING POLICIES** 

## **1.1 Company Information** 

Laboratory Animal Science Association is a private company limited by guarantee incorporated in England and Wales. The registered office is 6th Floor 9 Appold Street, London, England, EC2A 2AP. 

## **1.2 Basis of Preparation** 

A summary of the principal accounting policies adopted, judgements and key sources of estimation uncertainty, is set out below. 

The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). The company is a public benefit entity for the purposes of FRS 102 and a registered charity established as a company limited by guarantee and therefore has also prepared its financial statements in accordance with the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (The FRS 102 Charities SORP), the Companies Act 2006 and Charities Act 2011. 

The financial statements are prepared in sterling, which is the functional currency of the association. Monetary amounts in these financial statements are rounded to the nearest pound. 

The financial statements are prepared on the historical cost convention. The principal accounting policies adopted are set out below. 

## **1.3 Going Concern** 

The trustees have assessed whether the use of going concern is appropriate and have considered possible events or conditions that might cast significant doubt on the ability of the charity to continue  as a going concern. The trustees have made this assessment for a period of at least one year from the  date of approval of these financial statements. In particular, the trustees have considered the charity's forecasts and projections and have taken account of pressures on income. After making enquiries, the trustees have concluded that there is a reasonable expectation that the charity has adequate  resources to continue in operational existence for the foreseeable future. The charity therefore  continues to adopt the going concern basis in preparing its financial statements. 

## **1.4 Incoming resources** 

All incoming resources are recognised when the charity is entitled to the income, there is certainty of receipt and the monetary value can be measured with reasonable accuracy. 

Members subscriptions are recognised as income in the period to which they are received, and any relating to future periods are treated as deferred income in the Balance Sheet. 

## **1.5 Resources expended** 

Expenditure is included in the Statement of Financial Activities on an accruals basis. Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefit will be required in settlement and the amount of the obligation can be measured reliably. 

## **1.6 Allocation and apportionment of costs** 

All costs are allocated between the expenditure categories of the SOFA on a basis designated to reflect the use of the resources. Cost relating to a particular activity are allocated directly and others are apportioned on an appropriate basis. 

## **1.7 Fixed assets** 

Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less estimated residual value, over the expected useful life on the following basis: 

- Fixtures and Fittings **-** 33% on cost 

10 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

## Notes to the accounts 

For the year ended 30 June 2025 

## **1.8 Taxation** 

The charitable company is an exempt charity within the meaning of Schedule 3 of the Charities Act 2011 and is considered to pass the test set out in Paragraph 1 Schedule 6 Finance Act 2010 therefore it meets the definition of a charitable company for UK tax purposes. 

## **1.9 Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. 

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. 

## **1.10 Financial Instruments** 

## **a. Cash and cash equivalents** 

Cash and cash equivalents include cash at banks and in hand and short term deposits with a maturity date of three months or less. 

## **b. Debtors and creditors** 

Debtors and creditors receivable or payable within one year of the reporting date are carried at their transaction price. Debtors and creditors that are receivable or payable in more than one year and not subject to a market rate of interest are measured at the present value of the expected future receipts or payment discounted at a market rate of interest. 

## **1.11 Critical accounting judgements and key sources of estimation uncertainty** 

In the application of the accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factorsthat are considered to be relevant. Actual results may differ from these estimates. 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future 

|**2**<br>**INCOME FROM CHARITABLE ACTIVITIES**<br>Meetings<br>Certificate holders' Forum<br>LASA Forum<br>Training<br>Accommodation|**2025**<br>**£**<br>93,747<br>-<br>-<br>850<br>-<br>94,597|**2024**<br>**£**<br>149,930<br>20,615<br>1,115<br>-<br>1,080<br>172,740|
|---|---|---|



11 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

## Notes to the accounts 

For the year ended 30 June 2025 


**----- Start of picture text -----**<br>
3 INVESTMENT INCOME 2025 2024<br>£ £<br>Interest receivable 778 547<br>4 EXPENDITURE ON CHARITABLE ACTIVITIES Direct  Support  2025<br>YEAR TO 30 JUNE 2025 Costs Costs Total<br>£ £ £<br>Expenditure directly allocated to activities<br>Meetings 77,915 - 77,915<br>Support costs allocated to activities<br>Subscriptions and donations - 3,864 3,864<br>Bursaries and Honoria - 858 858<br>Administration costs - 28,243 28,243<br>Bank charges - 1,506 1,506<br>Website costs - 4,048 4,048<br>Travelling costs 4,314 4,314<br>Council expenses - 1,474 1,474<br>Legal and Professional - 252 252<br>Accountancy fees - 5,876  5,876<br>Loss on foreign currency translation - 28  28<br>Total  77,915 50,463 128,378<br>Direct  Support  2024<br>YEAR TO 30 JUNE 2024 Costs Costs Total<br>£ £ £<br>Expenditure directly allocated to activities<br>Newsletter 4,238 - 4,238<br>Certificate holders' forum 3,189 - 3,189<br>Meetings 95,935 - 95,935<br>Member publications 3,456 - 3,456<br>Support costs allocated to activities<br>Subscriptions and donations - 5,891 5,891<br>Bursaries and Honoria - 960 960<br>Administration costs - 25,772 25,772<br>CPD expenses - 47 47<br>Bank charges - 2,637 2,637<br>Website costs - 663 663<br>Council expenses - 2,625 2,625<br>Legal and Professional - 395  395<br>Accountancy fees - 4,405  4,405<br>Loss on foreign currency translation - 10  10<br>Total  106,818  43,405  150,223<br>**----- End of picture text -----**<br>


Included within support costs are governance costs of £7,601 (2024 - £7,425) All expenditure on charitable activities was unrestricted. 

12 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

## Notes to the accounts 

For the year ended 30 June 2025 

|**5**<br>**NET SURPLUS FOR THE YEAR IS STATED AFTER CHARGING:**<br>Independent Examination fees<br>Taxation fees<br>Prior year under-accrual|**2025**<br>**Total**<br>**£**<br>5,041<br>450<br>385|**2024**<br>**Total**<br>**£**<br>4,405<br>-<br>-|
|---|---|---|



## **6 EMPLOYEES** 

There were no staff employed by the Association in the year to 30 June 2025 nor 30 June 2024. 

## **7 TRUSTEES' REMUNERATION AND BENEFITS** 

There were no trustees' remuneration or other benefits for the year ended 30 June 2025 nor the year ended 30 June 2024. 

During the year, the charitable company paid £940 travel and accomodation expenses (2024: £0) to 2 (2024: 0) trustees. 

## **8 TANGIBLE FIXED ASSETS** 

|**Cost or valuation:**<br>At 1 July 2024 and 30 June 2025<br>**Depreciation:**<br>At 30 June 2024 and 30 June 2025<br>**Net Book Value:**<br>At 30 June 2024 and 30 June 2025<br>**9**<br>**DEBTORS**<br>Trade debtors<br>Prepayments|**2025**<br>**£**<br>-<br>6,561<br>6,561|**Fixtures &**<br>**Fittings**<br>**£**<br>**3,460**<br>**3,460**<br>**-**<br>**2024**<br>**£**<br>6,726<br>58,242<br>64,968|
|---|---|---|



Apart from prepayments, all debtors are financial instruments and are measured at present value. 

13 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

## Notes to the accounts 

For the year ended 30 June 2025 

|**10 CREDITORS DUE WITHIN ONE YEAR**<br>Trade creditors<br>Accruals and deferred income<br>VAT<br>Other creditors|**2025**<br>**£**<br>2,503<br>26,272<br>1,752<br>36,775<br>67,302|**2024**<br>**£**<br>28,151<br>29,043<br>2,126<br>37,147<br>96,467|
|---|---|---|



All creditors are financial instruments and are measured at present value. 

## **11 Unrestricted Funds** 

|General fund<br>General fund|**At**<br>**1 July 2024**<br>**£**<br>227,687<br>227,687<br>**At**<br>**1 July 2023**<br>**£**<br>167,398<br>167,398|**Incoming**<br>**Outgoing**<br>**£**<br>**£**<br>158,743<br>(128,378)<br>158,743<br>(128,378)<br>**Incoming**<br>**Outgoing**<br>**£**<br>**£**<br>210,512<br>(150,223)<br>210,512<br>(150,223)<br>**Movement in Resources**<br>**Movement in Resources**|**At**<br>**30 June 2025**<br>**£**<br>258,052<br>258,052<br>**At**<br>**30 June 2024**<br>**£**<br>227,687<br>227,687|
|---|---|---|---|



These funds are not by their nature allocated for any other purpose and are utilised for the general day to day tranactions and operations of the charitable company. 

## **12 SHARE CAPITAL** 

The company has no share capital and is limited by guarantee. 

## **13 RELATED PARTY TRANSACTIONS** 

During the year, the charitable company had conducted sales of £3,723 with RxCelerate Limited, a company in which a previous trustee (resigned January 2025) had significant control (2024: £15,355).  The balance at year end was £nil owed to the charitable company (2024: £618 owed to the charitable company). 

During the year, the charitable company had conducted sales of £nil ( 2024: £120) with NC3Rs, and received a donation of £nil (2024: £4,000) from NC3Rs, company in which a trustee has significant influence. No amounts were outstanding at the balance sheet date (2024: £nil). 

14 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

LABORATORY ANIMAL SCIENCE ASSOCIATION DETAILED STATEMENT OF FINANCIAL ACTIVITIES YEAR ENDED 30 JUNE 2025 



Docusign Envelope ID: 84D1E7C2-5454-41A8-A267-6AA4975094DD 

## LABORATORY ANIMAL SCIENCE ASSOCIATION 

## Detailed Statement of Financial Activities 

For the year ended 30 June 2025 


**----- Start of picture text -----**<br>
Unrestricted funds<br>2025 2024<br>£ £<br>INCOME<br>Voluntary income<br>Subscription 29,271 16,509<br>Sponsorships 33,264 20,716<br>Donations 833 -<br>63,368 37,225<br>Charitable activities<br>Meetings 93,747 149,930<br>Certificate holders' Forum - 20,615<br>LASA Forum - 1,115<br>Training 850 -<br>Accommodation - 1,080<br>94,597 172,740<br>Investment income<br>Interest receivable               778  547<br>Total incoming resources       158,743        210,512<br>EXPENDITURE<br>Charitable expenditure<br>Newsletter - 4,238<br>Certificate holders' forum - 3,189<br>Meetings 77,915 95,935<br>-<br>Member publications 3,456<br>        77,915        106,818<br>Support costs<br>Bursaries and awards 858 960<br>Subscriptions and donations 3,864 5,891<br>Administration costs 28,243 25,772<br>CPD expenses - 47<br>Bank charges 1,506 2,637<br>Website costs 4,048 663<br>-<br>Travelling 4,314<br>Council expenses 1,474 2,625<br>Legal and Professional 252 395<br>Accountancy fees 5,876 4,405<br>Loss on foreign currency translation 28 10<br>50,463 43,405<br>Total expenditure 128,378 150,223<br>Surplus for the year 30,365 60,289<br>**----- End of picture text -----**<br>


